Abstract
A one step synthesis of fluorescent 8-aryl-(7-deazaguanines) has been accomplished. Probes exhibit blue to green high quantum yield fluorescence in a variety of organic and aqueous solutions, high extinction coefficients, and large Stokes shifts often above 100 nm. The probes are highly cell permeable, and exhibit stable bright fluorescence once intracellular; therefore are suited to the design of biosensors.
Keywords: 8-aryl-7-deazaguanine; Fluorescent probes; 2,4-diamino-6-hydroxypyrimidine; Phenacyl bromides; Cellular permeability
Graphical Abstract
7-deazaguanine, nomenclature name 2-amino-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one, is an important modification of nucleotide base guanine where N7 is replaced by carbon.1 Naturally occurring 7-deazaguanines such as nucleotide Q, preQ, preQ0, and archaeosine serve as substrates of TGT enzymes that mediate their introduction into select tRNA of both eukaryotic and prokaryotic cells in place of guanine.2 This tRNA modification is thought to have significant impact on cellular proliferation, aging, and tumor progression. Applications of synthetic 7-deazaguanines in nucleic acid hybridization probes are important and well documented.3-5 Prominently chemotherapeutic drugs based on 7-deazaguanine are capable of a multitude of interactions with intracellular enzymes of the folic acid cycle that are indispensable to cellular proliferation such as TS, DHFR, GARF, and cellular membrane transporters such as folate receptors (FRα, FRβ, RFC, PCFT).6-8 In light of the importance of this motif in the biochemistry of living cells, we investigated the design of fluorescent probes around 7-deazaguanine. In terms of precedent, fluorescent 8-aryl-7-deazaguanines (8aryl7DGs) were not described in literature. However, extension of the π-system of guanine itself at the 8-position with various aromatic motifs results in highly fluorescent probes.9 Therefore, we hypothesized that 7-deazaguanine analogs would exhibit similar fluorescence emission.10-14 Data presented here far exceeded our expectations. Specific experimental procedures for the synthesis of 8aryl7DGs were not published. Often 7-deazaguanines are obtained using the addition-condensation reaction by Secrist III (Scheme 1).15 We implemented the above protocol with minor modifications. 8aryl7DGs were obtained as single products in high yields by reacting equivalent molar amounts of commercially available 2,4-diamino-6-hydroxypyrimidine 2 and substituted phenacyl bromides 1(a-l). We found that using Et3N in 1,4-dioxane instead of the usual sodium acetate in THF-water mixture led to simple and efficient purification by precipitation in water. Due to mild reaction conditions, a wide range of substrates is tolerated.
Scheme 1.
One step syntheses of hydrophobic 8aryl7DG
The SN2 reaction between nucleophilic C5 of pyrimidine 2 and phenacyl bromides 1 determines the regiochemistry of the final products, of which there was no ambiguity. Our spectral data were compared, and are substantially different from, published data on 7aryl7DG regioisomers.16 This synthetic work adds to an already rich literature on 7DG. There is interest in efficient syntheses of 8aryl7DG as intermediates of pharmacologically active lead compounds.17 A similar synthesis of 8aryl7DGs was recently reported in literature without any experimental or spectroscopic details.18 Our protocol was developed independently prior to this publication.19
Three other 8aryl7DGs were produced from 3c, according to literature protocol, as shown in scheme 2.16
Scheme 2.
Syntheses of hydrophilic 8aryl7DG
8aryl7DGs are freely soluble in DMSO; therefore, samples were prepared from DMSO stock solutions diluted in the appropriate solvent to less than 2% DMSO. Fluorescence emission and absorption spectra were measured in DMSO, diluted aqueous solutions, and 10 % fetal bovine serum (FBS) in phosphate buffer, which are most likely to be used in biological applications. Optical properties are summarized Tables 1-3. Detailed spectra in various organic and aqueous solvents for each probe are included in SI. With the exception of nitro substituted, all 8aryl7DGs exhibit above average to excellent quantum yields in DMSO. All scenarios of fluorescence modulation are observed: moderate changes in fluorescence in all mediums (3b, 3h, 3j), several fold increase in fluorescence intensity from DMSO to bovine serum solutions (3k, 3l), as well as the opposite (3a, 3c, 3e). The probes can be thought of as refinements of core 8Ph7DG (3a). Introducing methoxy group (3e, 3h) leads to high quantum yield blue fluorescence. Introducing bromine leads to poor fluorescence (3d). No change in λem~400nm is observed compared to 3a. Stokes shifts measure ~ 80nm (fig.1A). One can fine-tune fluorescence properties compared to 3a to higher λem ~450-470 nm by extending the aryl system (3b, 3j) or introducing groups such as CN (3c), CO2H (3m), and amide (3n). These probes exhibit excellent green fluorescence, and large Stokes shift often >100nm (fig. 1B). Attaching two known hydrocarbon fluorophores such as pyrene and antracene to 7DG results in probes 3k, 3l with extraordinary large Stokes shifts in DMSO, 146nm and 202nm, respectively (Table 1), and maximum λem~530nm (fig.1C). All probes exhibit equal or higher fluorescence emission intensities in organic solvents such as DMF, CHCl3, acetonitrile, 1,4-dioxane compared to DMSO (see SI, pg8). The highly hydrophobic 3k (8pyr7DG) and 3l (8anthra7DG) exhibit a 2-4 fold increase in fluorescence emission intensity in benzene, chloroform and 1,4-dioxane compared to DMSO (figs.SI-25, SI-28). As expected, 8aryl7DGs experience various degrees of fluorescence quenching in methanol and aqueous solutions (SI, pg8). However, most probes exhibit analytically viable quantum yields ΦF>0.1 in 10% FBS solutions, and often above average ΦF~0.2-0.5 (Table 2). Impressively, six out of 13 8aryl7DGs retain high quantum yield fluorescence either in pure water, or basic aqueous solutions, often in higher values compared to serum (3a, 3b, and 3h). Fluorescence emission of all probes is quenched in acidic solutions, except for probe 3b.
Table 1.
Fluorescence properties, ε (M−1cm−1), λ (nm), measured in DMSO
3a | 3b | 3c | 3d | 3e | 3g | 3h | 3j | 3k | 3l | 3m | 3n | 3o | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
λ abs | 328 | 355 | 382 | 340 | 319 | 350 | 329 | 342 | 384 | 344 | 365 | 358 | 359 |
λ em | 401 | 470 | 474 | 403 | 402 | 432 | 399 | 474 | 530 | 546 | 410 | 468 | 467 |
Δ λ | 73 | 115 | 92 | 63 | 83 | 82 | 70 | 132 | 146 | 202 | 45 | 100 | 108 |
ε | 20,634 | 22,772 | 21,227 | 18,243 | 20,615 | 11,640 | 15,204 | 21,188 | 11,906 | 29,422 | 18,224 | 13,231 | 12,503 |
Φ | 0.96 | 0.70 | 0.84 | 0.04 | 0.55 | 0.78 | 0.80 | 0.69 | 0.09 | 0.08 | 0.52 | 0.85 | 0.13 |
Table 3.
Fluorescence properties, ε (M−1cm−1), λ (nm), measured in distilled water.
3a(1) | 3b | 3c | 3d | 3e | 3g | 3h(1) | 3j | 3k | 3l | 3m | 3n | 3o | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
λ abs | 322 | 331 | 351 | 318 | 306 | 327 | 325 | 329 | - | - | 336 | 342 | 340 |
λ em | 410 | 461 | 476 | 400 | 403 | 416 | 415 | 482 | - | - | 466 | 491 | 509 |
Δ λ | 88 | 129 | 125 | 82 | 97 | 89 | 80 | 153 | - | - | 110 | 149 | 169 |
ε | 22,051 | 16,229 | 23,120 | 17,743 | 19,403 | 10,842 | 14,278 | 17,525 | - | - | 19,110 | 12,829 | 11,405 |
Φ | 0.27 | 0.68 | 0.05 | 0.0015 | 0.006 | 0.32 | 0.55 | 0.21 | - | - | 0.18 | 0.05 | 0.006 |
Probes dissolved in 10mM NaOH in distilled water.
Figure 1.
A, B, C. Normalized fluorescence excitation (dashed lines) and emission spectra (solid lines) in DMSO.
Table 2.
Fluorescence properties, ε (M−1cm−1), λ (nm), measured in 10% FBS in phosphate buffer.
3a | 3b | 3c | 3d | 3e | 3g | 3h | 3j | 3k | 3l | 3m | 3n | 3o | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
λ abs | 318 | 343 | 354 | 326 | 310 | 336 | 316 | 337 | 378 | 339 | 341 | 343 | 344 |
λ em | 385 | 431 | 466 | 405 | 381 | 413 | 390 | 436 | 496 | 504 | 455 | 487 | 484 |
Δ λ | 77 | 88 | 112 | 79 | 71 | 77 | 86 | 99 | 118 | 165 | 114 | 144 | 140 |
ε | 16,696 | 18,940 | 19,093 | 15,764 | 19,592 | 9,892 | 13,823 | 17,330 | 10,290 | 14,320 | 18,958 | 10,485 | 11,263 |
Φ | 0.12 | 0.40 | 0.19 | 0.03 | 0.017 | 0.50 | 0.14 | 0.38 | 0.27 | 0.30 | 0.23 | 0.10 | 0.057 |
Next we proceeded to test the cellular permeability of 8aryl7DGs. Two human cell lines were used: nasopharyngeal (KB) cancer cells and A549 lung cancer cells. The toxicity of the probes on both cell lines is minimal at physiological levels of use. In repeated measurements, we were unable to find an IC50 using the XTT assay in concentrations up to 20μM. Probes exited optimally at λex~350nm were imaged using a low resolution optical microscope equipped with a DAPI fluorescence filter. Probe 3k (8pyr7DG) that is exited optimally at λex=405nm was imaged using a high resolution confocal microscope. KB and A549 cells were stained at 37°C, 5% CO2, 95 % air, in RPMI 1640 growth medium containing probes at 1-20μM concentrations. No cellular uptake was observed for hydrophilic probes 3c, 3m and 3n at 5μM and 20μM concentration. This result was expected based on sequestration by serum proteins of probes, which are anionic under incubating conditions. On the other hand, hydrophobic 3b, 3j, 3k, and 3l exhibited high cellular uptake and stability inside cells. Perhaps most informative are confocal microscopy images of cells stained with 1μM solution of probe 3k (fig. 2). Within minutes, intracellular fluorescence is observed. Images were taken successively for 2 hours. The complete set of low and high resolution images is included in SI. Note that probes remain largely cytosolic upon prolonged exposure with little to no fluorescence observed in the nuclear compartments in low and high resolution microscopy. This suggests receptor mediated uptake as efflux mechanisms might be working in tandem with free diffusion cellular uptake.
Figure 2.
Confocal microscopy single slice images of A549 and KB cells stained with 1μM solution of 3k for 15 min.
In conclusion, the diversity of the library examined suggests any 8-aryl-7-deazaguanine could be an above average fluorophore. Bright fluorescence in the blue to green region and large Stokes shifts are some of the qualities observed. It is important for future biological applications that fluorescence properties are preserved in aqueous solutions, and in some instances enhanced in 10 % FBS in phosphate buffer. Functional groups introduced into the aryl frame of 8Ph7DG (3a) have defined effects on fluorescence properties causing ~80nm redshift to λem~465-480nm for phenyl, CN, CO2H and amide groups, and λem~530nm for larger aryl groups such as pyrene or anthracene. Diversity-oriented synthesis of larger fluorophore libraries is possible because 8aryl7DG core is assembled in one step from readily available starting materials. This process will facilitate identification of probes for specific future applications. Few fluorescent C8-arylguanine designs are used to study the reaction of phenoxyl radical with DNA strands.11,20 C8-arylguanines are reported to stabilize GG mismatches and to stabilize the transition from B-DNA to Z-DNA as well.21,22 Therefore, 8aryl7DGs being isosteric might find immediate applications. It is well known that groups appended to the 7-position of 7-deazaguanine are known to accommodate better within the major groove of the DNA duplexes.3 Thus, designing an analogous fluorescent 7aryl7DG series to complement the available 8aryl7DG series is a priority. Importantly, there is room for improving fluorescence properties. Introducing polyene bridges into 7-deazaguanine, and/or heterocyclic chromophores in designs which are similar to cyanine dyes could lead to near infrared probes with λem >600nm which are better suited for optical spectroscopy and imaging applications, in vivo. Hydrophobic 8aryl7DGs exhibited excellent cellular permeability in low concentrations and no apparent toxicity; therefore, are suited to the design of biosensors.
Supplementary Material
Acknowledgments
This work was supported by the Pulmonary Division of the Department of Internal Medicine, the Ohio State University Medical College, and NIH grant R03 EB016859. The authors thank Dr. Sara Cole, assistant director of Campus Microscopy & Imaging Facility (CMIF) of the Ohio State University.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Supplementary data associated with this work, including synthetic procedures, NMR, HRMS, absorbance and fluorescence spectra can be found in the online version.
References and notes
- (1).Bruckl T, Klepper F, Gutsmiedl K, Carell T. Org Biomol Chem. 2007;5:3821. doi: 10.1039/b713309j. [DOI] [PubMed] [Google Scholar]
- (2).Morris RC, Elliott MS. Mol Genet Metab. 2001;74:147. doi: 10.1006/mgme.2001.3216. [DOI] [PubMed] [Google Scholar]
- (3).Ingale SA, Pujari SS, Sirivolu VR, Ding P, Xiong H, Mei H, Seela F. J Org Chem. 2012;77:188. doi: 10.1021/jo202103q. [DOI] [PubMed] [Google Scholar]
- (4).Guo J, Yu L, Turro NJ, Ju J. Acc Chem Res. 2010;43:551. doi: 10.1021/ar900255c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (5).Meng QL, Kim DH, Bai XP, Bi LR, Turro NJ, Ju JY. J Org Chem. 2006;71:3248. doi: 10.1021/jo060300k. [DOI] [PubMed] [Google Scholar]
- (6).Chattopadhyay S, Moran RG, Goldman ID. Mol Cancer Ther. 2007;6:404. doi: 10.1158/1535-7163.MCT-06-0343. [DOI] [PubMed] [Google Scholar]
- (7).Cherian C, Wang YQ, Mitchell-Ryan S, Orr S, Hou ZJ, Gangjee A, Matherly LH. Cancer Res. 2013;73 [Google Scholar]
- (8).Mitchell-Ryan S, Wang YQ, Raghavan S, Ravindra MP, Hales E, Orr S, Cherian C, Hou ZJ, Matherly LH, Gangjee A. J Med Chem. 2013;56:10016. doi: 10.1021/jm401328u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (9).Sinkeldam RW, Greco NJ, Tor Y. Chem Rev. 2010;110:2579. doi: 10.1021/cr900301e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (10).Zilbershtein L, Silberman A, Fischer B. Organic & Biomolecular Chemistry. 2011;9:7763. doi: 10.1039/c1ob05681f. [DOI] [PubMed] [Google Scholar]
- (11).Manderville RA, Omumi A, Rankin KM, Wilson KA, Millen AL, Wetmore SD. Chem Res Toxicol. 2012;25:1271. doi: 10.1021/tx300152q. [DOI] [PubMed] [Google Scholar]
- (12).Matsumoto K, Takahashi N, Suzuki A, Morii T, Saito Y, Saito I. Bioorg Med Chem Lett. 2011;21:1275. doi: 10.1016/j.bmcl.2010.11.129. [DOI] [PubMed] [Google Scholar]
- (13).Greco NJ, Tor Y. Tetrahedron. 2007;63:3515. doi: 10.1016/j.tet.2007.01.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (14).Wanninger-Weiss C, Valis L, Wagenknecht HA. Bioorganic & medicinal chemistry. 2008;16:100. doi: 10.1016/j.bmc.2007.04.064. [DOI] [PubMed] [Google Scholar]
- (15).Secrist JAL, III, P. S. J. Org. Chem. 1978;43:3937. [Google Scholar]
- (16).Taylor EC, Liu B. J Org Chem. 2003;68:9938. doi: 10.1021/jo030248h. [DOI] [PubMed] [Google Scholar]
- (17).Khalaf AI, Huggan JK, Suckling CJ, Gibson CL, Stewart K, Giordani F, Barrett MP, Wong PE, Barrack KL, Hunter WN. J Med Chem. 2014;57:6479. doi: 10.1021/jm500483b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Gao LJ, Schwed JS, Weizel L, De Jonghe S, Stark H, Herdewijn P. Bioorg Med Chem Lett. 2013;23:132. doi: 10.1016/j.bmcl.2012.10.139. [DOI] [PubMed] [Google Scholar]
- (19).Dhimitruka I. Wayne State University, PhD thesis. 2004. [Google Scholar]
- (20).Omumi A, Beach DG, Baker M, Gabryelski W, Manderville RA. Journal of the American Chemical Society. 2011;133:42. doi: 10.1021/ja106158b. [DOI] [PubMed] [Google Scholar]
- (21).Omumi A, Millen AL, Wetmore SD, Manderville RA. Chem Res Toxicol. 2011;24:1694. doi: 10.1021/tx200247f. [DOI] [PubMed] [Google Scholar]
- (22).Gannett PM, Heavner S, Daft JR, Shaughnessy KH, Epperson JD, Greenbaum NL. Chem Res Toxicol. 2003;16:1385. doi: 10.1021/tx034023d. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.